. 2012 Dec;20(4):235–237. doi: 10.5455/aim.2012.20.235-237
© 2012 AVICENA
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 2.
Malignancy as indication for PEG placement.